BioSpace News Archive

Business

Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific

Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport” or the “Company”), and Mitsubishi Logistics Corporation (“MLC”), Japan’s leading pharma logistics company, today announced a multi-year strategic business alliance to create an integrated regenerative medicine supply chain partnership in Japan.

August 25, 2021
·
4 min read
Business

Rapid Dose Therapeutics Reports Q1 Financial Results and Exercise of Warrant for Net Proceeds of $689,000

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), today reported its Q1 financial results.

August 25, 2021
·
4 min read
Genetown

Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 19th Annual Morgan Stanley Virtual Global Healthcare Conference on Thursday, September 9, 2021, at 8:45 a.m. ET.

August 25, 2021
·
1 min read
Pharm Country

Cigna Corporation Announces Appearance at the Morgan Stanley 19th Annual Global Healthcare Conference

Global health service company Cigna Corporation (NYSE:CI) announced today that David Cordani, president and chief executive officer, will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 14, 2021 through a virtual webcast.

August 25, 2021
·
1 min read
BioCapital

Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems

Novavax, Inc. (Nasdaq: NVAX), today announced that Novavax’ recombinant nanoparticle protein vaccine candidate is being studied in OCTAVE-DUO, now underway in the UK to evaluate the safety and immunogenicity of a third COVID-19 vaccine dose in participants with impaired immune systems.

August 25, 2021
·
6 min read
FDA

Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine

Moderna, Inc. today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older.

August 25, 2021
·
9 min read
Drug Development

Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates Phase 2 for CPI-613® (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer

Rafael Pharmaceuticals, Inc. today announced the successful completion of a Phase 1b clinical trial of CPI-613 ® (devimistat) in combination with gemcitabine and cisplatin in patients with biliary tract cancer.

August 25, 2021
·
4 min read
Deals

AccessDX Holdings Acquires 2bPrecise

AccessDX Holdings, an international provider of advanced laboratory diagnostic solutions, has acquired 2bPrecise™ from Allscripts Healthcare Solutions

August 25, 2021
·
4 min read
Syringes Market Size Worth $32.39 billion by 2027 with Top key players Becton, Gerresheimer AG, Nipro Medical

Rise in incidence of needle stick injuries, increase in awareness about smart syringes, and high-end technological advancements drive the growth of the global syringes market.

August 25, 2021
·
4 min read
Business

Rubicon Founders Launches Evergreen Nephrology to Transform Kidney Care with Balboa Nephrology Medical Group

Evergreen Nephrology will partner with nephrologists to transform kidney care for patients across the United States

August 25, 2021
·
5 min read